Controlled hypotension is used frequently during intracranial aneurysm surgery, since it decreases both the risk of rupture of the aneurysm, and the mortality rate attributable to this type of surgery (Viars et al., 1976) . However, the choice of technique and the ideal arterial pressure remain controversial. The ideal arterial pressure varies from 60 mm Hg to less than 40 mm Hg (Pertuiset et al., 1974; Chestnut et al., 1978) , although the value quoted most frequently is 50 mm Hg.
Ganglionic blocking drugs and halothane are used less frequently than in the past. Sodium nitroprusside (SNP), introduced by Moraca and colleagues (1962) , has been used widely because of its ability to induce rapid, reversible hypotension. However, it is known that this drug has certain potentially harmful side-effects, so that nitroglycerine (TNG) has been considered seriously by certain workers (Fahmy, 1978) . Nitroglycerine is a non-toxic vasodilator which easily induces moderate hypotension. However, the question remains whether this drug can be used for hypotension equal to or greater than 50 mm Hg, and certain authors have noted that this value cannot be obtained without supplementation. Numerous studies have recorded the haemodynamic effects of TNG alone (Chestnut et al., 1978; Urcioli et al., 1980; Lagerkranser, 1982) but not with adjuvant drugs and not under general anaesthesia.
The aims of this study were first to determine whether TNG used alone (in association with general anaesthesia) could decrease arterial pressure to less than 50 mm Hg and, second, if whether SNP could be used to supplement the action of TNG to obtain the desired hypotension.
PATIENTS AND METHODS

Patients
After all patients had given informed consent and the experimental programme had been approved by the hospital ethics committee, 30 patients (14 female) were studied. Their average age was 40 ± 13yr (mean ± SD) and their mean weight 63.9 ± 12.9 kg (mean ± SD). All patients had a ruptured intracranial aneurysm and were in Grades 1 or II (Hunt and Hess, 1968) . None had clinical evidence of cardiac insufficiency.
General anaesthesia
Premedication consisted of sublingual diazepam 10 mg. After an injection of atropine 0.5 mg i.v., thiopentone 5 mg kg" 1 was administered. This was followed by suxamethonium 1 mg kg" 1 to facilitate tracheal intubation. Anaesthesia was maintained with repeated doses of phenoperidine (total dose 7.72 ± 1.24 mg (mean ± SD)) and droperidol (total dose 39.8 ± 11.8 mg (mean ± SD)), and a mixture of 60% nitrous oxide in oxygen. Ventilation was controlled to maintain PaCO 2 between 4 and 4.8 kPa. All patients were operated in the supine position. Mannitol 0.5 mg kg~' was administered to three patients before the induction of deliberate hypotension.
Controlled hypotension
Hypotension was induced with an infusion i.v. of TNG in propylene glycol solution 45 mg in 30 ml using a polypropylene syringe, and polyethylene tubing. The infusion was started during the dissection of the aneurysm and discontinued after successful ligation. The infusion rate was adjusted to achieve the desired value of arterial pressure (less than 50 mm Hg). When it was possible to attain the intended mean arterial pressure (MAP) (50 mm Hg) the patients were called "sensitive" and when this value was unobtainable, despite what was considered a maximum TNG infusion rate, patients were called "resistant". In those "resistant" patients in whom it appeared essential to decrease MAP to less than 50mm Hg, SNP 0.5-2 jig k g ' 1 min" 1 was administered via another vein, in addition to the TNG, which was maintained at the same maximum flow of 30 ug kg" 1 min "'.
Haemodynamic measurements
A cannula was inserted to the radial artery and arterial pressure measured. Following the induction of anaesthesia, a 7F flow-directed catheter was inserted and advanced until its tip wedged in a small branch of the pulmonary artery. Right atrial pressure (RAP), pulmonary artery pressure (PAP) and pulmonary capillary wedge pressure (PCWP) were recorded continuously on a multichannel recorder (Hewlett-Packard). Cardiac output (CO) was determined in triplicate, using the thermodilution technique (Hewlett-Packard) and the mean value was used. Heart rate (HR) was recorded continuously (Hewlett-Packard). Cardiac index (CI) was calculated using the formula:
Stroke volume (SV) was calculated using the formula: SV = C I x 1000 (ml m" 2 )
HR
Systemic vascular resistance (SVR) was calculated using the formula: SVR = MAP-RAP(kPa litre" 1 min" 1 m" 2 )
CI
Pulmonary vascular resistance (PVR) was calculated using the formula:
In all patients (n = 30), haemodynamic measurements were obtained before the induction of deliberate hypotension (T\), at the time of maximum hypotension with TNG alone (T 2 ) and 30 min after the discontinuation of the drug infusion (T 3 ). In certain patients (n = 7) haemodynamic data were recorded at an intermediary stage-around 50 mm Hg. When SNP was administered, haemodynamic measurements were taken once the maximum degree of hypotension had been achieved.
Blood analyses
In 19 patients, arterial and mixed venous bloodgas tensions were measured at T\ and T 2 . Arteriovenous oxygen content difference (CzOi -CvOi) and total oxygen uptake (Vo 2 ) were calculated using standard formulae. Blood samples were taken in all 30 patients at 7* l5 T 2 and T 3 and plasma renin activity (PR A) measured.
The data presented are mean values ± the standard deviation (SD) or the standard error of the mean (SEM) and include first, the overall values when the most profound degree of hypotension had been obtained with TNG alone (n = 30); second, a comparison between values obtained in the "sensitive" group and the "resistant" group; and third, values obtained in "resistant" patients once SNP had been administered.
The statistical significance of the results was determined using the Student's t test for paired and unpaired data. The correlation r was the coefficient used to identify the significance of the linear regression; P < 0.05 was considered significant. The general characteristics of all the patients, both "sensitive" and "resistant", under controlled hypotension are shown in table I.
RESULTS
All patients
The results obtained for all patients are presented in table II: MAP decreased by 43% and PAP decreased by 48%. These results are related to a decrease both in CI (18%) and in peripheral resistances (SVR 30%, PVR 21%). A significant linear relation (P < 0.001) existed between the decrease in CI as a percentage and that of MAP: %MAP = 0.58 %CI -33, r = 0.67. The greatest decrease in CI was 58% for an MAP of 26.3 mm Hg. HR increased moderately (7%) although there were variations (seven instances of sino-bradycardia < 50 beat min" 1 at maximum hypotension) between individuals.
The mean increase in PRA of 90% was significant. Blood-gas tensions showed a moderate increase in (CaO 2 -CvO 2 ) from 33 ± 3 to 40 ± 4 vol litre" 1 , whereas Vo 2 was not statistically modified, PaO 2 decreased from 22.3 ± 1.6 to 16.1 ± 1.7 kPa (P < 0.05) accompanied by an increase in venous admixture from 11.7 ± 2% to 15.9 ± 2.5% (P < 0.05).
Comparison of "sensitive" and "resistant" patients
The mean value of MAP was 44.4 mm Hg for the whole group of 30 patients, but in 11 patients we were unable to achieve an MAP of less than 50 mm Hg. The "resistant" group differed from the "sensitive" group (table III), in that decreases in CI (2% compared with 27%) and SVR (22% compared with 35%) were less marked, whereas the increase in HR (12% compared with 3%) was greater. These differences disappear, however, if we consider comparable arterial pressures in both "resistant" (table III) and "sensitive" patients (table  IV) . In this case and for MAP between 50 and 60 mm Hg, the increase in HR was identical (12%) and no significant difference in CI was observed between the two groups. The three patients who received mannitol were all in the "sensitive" group.
Combination of TNG + SNP
In nine of the 11 "resistant" patients, arterial pressure had to be deliberately decreased below 50 mm Hg (table V) . When MAP was decreased another 31%, CI and HR increased slightly (CI 8%,
DISCUSSION
The results suggest that TNG can be administered to patients under general anaesthesia and controlled ventilation to obtain controlled decreases in arterial (Cyong et al., 1976; Vatneretal., 1978) . Venous return decreased, as shown by decreased filling pressures (RAP and PCWP) and a decrease in SI. The result was a decrease in SVR (30%) and CI (Lagerkranser, 1982) . On average, this decrease in CI was moderate (18%) but depended on the ultimate value of MAP (correlation between MAP and CI). Compared with nitroprusside, with which there are biphasic changes in CI (Stoyka and Schutz, 1975) , CI does not increase in the case of moderate MAP (50 -60 mm Hg) with TNG, possibly as a result of the very slight increase in HR. Nevertheless, in onethird of the patients, TNG used alone was inadequate to achieve hypotension of less than 50 mm Hg.
In "sensitive" patients MAP 35 mm Hg was obtained using doses of TNG 0.8 mg min (at a rate of 5-20 \ig kg" 1 min" 1 ). This decrease in MAP was, as in all the patients, the result of decreases in SVR and CI. As for moderate values of MAP, HR increased significantly, but this was insufficient to counterbalance the effects of the decreases in SVR and venous return on CI (Lagerkranser, 1982) . At (Come and Pitt, 1976) . Till now, no satisfactory explanation has been given of this phenomenon in "resistant" patients. Several hypotheses can be proposed: First, the dose of TNG used. In our study doses were higher in "resistant" patients (up to 30 jxg kg" 1 min" 1 ). We considered this to be the maximum dose, because efficacy at higher doses had not been demonstrated, and we wished to avoid the risk of secondary haemoglobinuria from an overdose of propylene glycol (Brittain and D'Arcy, 1962) . Before the study, two cases of transitory haemoglobinuria were noted after administration of doses of more than 30 H-g kg" 1 min"* 1 ). Tannieres and colleagues (1979) could not achieve hypotension of 50 mm Hg even after using TNG 50 |xg kg" 1 min"
1 . Nevertheless, their anaesthetic was different: notably the fact that droperidol was not used, or was used at smaller doses (0.26 mg kg" 1 ). Second, there could be alterations in circulating hormone concentrations. However, PRA (at T x and T 2 ) was not different between "sensitive" and "resistant" patients, despite the fact that with SNP a relationship exists between resistance to the drug and increases in PRA concentration (Lienhart et al., 1979) .
Third, a different haemodynamic behaviour could be involved. When comparing "resistant" and "sensitive" patients at a comparable value of MAP between 50 and 60 mm Hg, the results were identical, particularly the decreases in CI and SVR, and the increase in HR. The fact that HR then decreased in "sensitive" patients at low values of MAP cannot be considered a significant difference since, at T 2 , HR in the two groups was not significantly different and, in addition, in the sensitive group the decrease in HR between MAP = 50 mm Hg and T 2 was not significant.
In resistant patients the addition of small doses of SNP was effective and tolerated well, since CI was increased rather than decreased. The doses of SNP ( < 2 |^g kg" 1 min" 1 ) were well below the toxic level (Ivankovich et al., 1983) .
TNG would appear to be free of metabolic sideeffects (Lagerkranser, 1982) because the decrease in CI is combined with an increase in (CaO 2 -CvO 2 ) without changes in Vo 2 . Compared with SNP, no post-hypotensive rebound effect was observed and this fact could possibly be associated with a more moderate increase in PRA during hypotension with TNG, than with SNP (Lienhart et al., 1979) .
In summary, TNG induced rapid, stable and reversible hypotension (Chestnut et al., 1978) to around 50 mm Hg, but was accompanied by a decrease in cardiac output proportional to the decrease in arterial pressure. In one-third of all patients 50 mm Hg was unobtainable, but the addition of SNP proved effective and was well tolerated by these particular patients.
